Targeting Antibiotic Resistance

Finding strategies against the development of antibiotic resistance is a major global challenge for the life sciences community and for public health. The past decades have seen a dramatic worldwide increase in human‐pathogenic bacteria that are resistant to one or multiple antibiotics. More and more infections caused by resistant microorganisms fail to respond to conventional treatment, and in some cases, even last‐resort antibiotics have lost their power. In addition, industry pipelines for the development of novel antibiotics have run dry over the past decades. A recent world health day by the World Health Organization titled “Combat drug resistance: no action today means no cure tomorrow” triggered an increase in research activity, and several promising strategies have been developed to restore treatment options against infections by resistant bacterial pathogens.     

A Supramolecular Antibiotic Switch for Antibacterial Regulation

A supramolecular antibiotic switch is described that can reversibly “turn‐on” and “turn‐off” its antibacterial activity on demand, providing a proof‐of‐concept for a way to regulate antibacterial activity of biotics. The switch relies on supramolecular assembly and disassembly of cationic poly(phenylene vinylene) derivative (PPV) with cucurbit[7]uril (CB[7]) to regulate their different interactions with bacteria. This simple but efficient strategy does not require any chemical modification on the active sites of the antibacterial agent, and could also regulate the antibacterial activity of classical antibiotics or photosensitizers in photodynamic therapy. This supramolecular antibiotic switch may be a successful strategy to fight bacterial infections and decrease the emergence of bacterial resistance to antibiotics from a long‐term point of view.     

Glyconanomaterials for Combating Bacterial Infections

Bacterial infections constitute an increasing problem to human health in response to build‐up of resistance to present antibiotics and sluggish development of new pharmaceuticals. However, a means to address this problem is to pinpoint the drug delivery to—and into—the bacteria. This results in a high local concentration of the drug, circumventing the increasingly high doses otherwise necessary. Combined with other effectors, such as covalent attachment to carriers, rendering the drugs less degradable, and the combination with efflux inhibitors, old drugs can be revived. In this context, glyconanomaterials offer exceptional potential, since these materials can be tailored to accommodate different effectors. In this Concept article, we describe the different advantages of glyconanomaterials, and point to their potential in antibiotic “revitalization”.     

Chemical and Biological Aspects of Nutritional Immunity—Perspectives for New Anti‐Infectives that Target Iron Uptake Systems

Upon bacterial infection, one of the defense mechanisms of the host is the withdrawal of essential metal ions, in particular iron, which leads to “nutritional immunity”. However, bacteria have evolved strategies to overcome iron starvation, for example, by stealing iron from the host or other bacteria through specific iron chelators with high binding affinity. Fortunately, these complex interactions between the host and pathogen that lead to metal homeostasis provide several opportunities for interception and, thus, allow the development of novel antibacterial compounds. This Review focuses on iron, discusses recent highlights, and gives some future perspectives which are relevant in the fight against antibiotic resistance.     

A β‐Lactamase‐Imprinted Responsive Hydrogel for the Treatment of Antibiotic‐Resistant Bacteria

Antibiotics play important roles in infection treatment and prevention. However, the effectiveness of antibiotics is now threatened by the prevalence of drug‐resistant bacteria. Furthermore, antibiotic abuse and residues in the environment cause serious health issues. In this study, a stimuli‐responsive imprinted hydrogel was fabricated by using β‐lactamase produced by bacteria for deactivating antibiotics as the template molecule. The imprinted hydrogel could initially trap β‐lactamase excreted by drug‐resistant bacteria, thus making bacteria sensitive to antibiotics. After the bactericidal treatment, the “imprinted sites” on the hydrogel could be reversibly abolished with a temperature stimulus, which resulted in the reactivation of β‐lactamase to degrade antibiotic residues. We also present an example of the use of this antibacterial design to treat wound infection.     

Biological Characterization of Ingredients in OPLC-BioArena-Greenhouse-System: Unique Reactions of Endogenous HCHO and O3 in In Vitro and In Vivo Conditions

In the case of two “old medicines”, the extension of the results from the in vitro BioArena studies was successfully solved for in vivo (greenhouse) conditions. These preliminary results of in vitro and in vivo studies confirmed the unique role and function of HCHO and O₃ in the antibiotic effect of these two chemical substances, and in the basal and induced resistance. In the future, for the characterization of known and new active substances, in vitro and in vivo biological studies will be recommended in addition to chemical and physical characterization.

     

Molecular mechanisms of antibiotic resistance

Over the past decade, resistance to antibiotics has emerged as a crisis of global proportion. Microbes resistant to many and even all clinically approved antibiotics are increasingly common and easily spread across continents. At the same time there are fewer new antibiotic drugs coming to market. We are reaching a point where we are no longer able to confidently treat a growing number of bacterial infections. The molecular mechanisms of drug resistance provide the essential knowledge on new drug development and clinical use. These mechanisms include enzyme catalyzed antibiotic modifications, bypass of antibiotic targets and active efflux of drugs from the cell. Understanding the chemical rationale and underpinnings of resistance is an essential component of our response to this clinical challenge.     

Chemiluminescent Carbapenem-Based Molecular Probe for Detection of Carbapenemase Activity in Live Bacteria

Carbapenemase-producing organisms (CPOs) pose a severe threat to antibacterial treatment due to the acquisition of antibiotic resistance. This resistance can be largely attributed to the antibiotic-hydrolyzing enzymes that the bacteria produce. Current carbapenem “wonder drugs”, such as doripenem, ertapenem, meropenem, imipenem, and so on, are resistant to regular β-lactamases, but susceptible to carbapenemases. Even worse, extended exposure of bacteria to these drugs accelerates the spread of resistance genes. In order to preserve the clinical efficacy of antibacterial treatment, carbapenem drugs should be carefully regulated and deployed only in cases of a CPO infection. Early diagnosis is therefore of paramount importance. Herein, we report the design, synthesis, and activity of the first carbapenemase-sensitive chemiluminescent probe, CPCL , which may be used to monitor CPO activity. The design of our probe enables enzymatic cleavage of the carbapenem core, which is followed by a facile 1,8-elimination process and the emission of green light through rapid chemical excitation. We have demonstrated the ability of the probe to detect a number of clinically relevant carbapenemases and the successful identification of CPO present in bacterial cultures, such as those used for clinical diagnosis. We believe that our use of “turn-on” chemiluminescence activation will find significant application in future diagnostic assays and improve antibacterial treatment.     

3D cell culture models and organ-on-a-chip: Meet separation science and mass spectrometry

In vitro derived simplified 3D representations of human organs or organ functionalities are predicted to play a major role in disease modeling, drug development, and personalized medicine, as they complement traditional cell line approaches and animal models. The cells for 3D organ representations may be derived from primary tissues, embryonic stem cells or induced pluripotent stem cells and come in a variety of formats from aggregates of individual or mixed cell types, self-organizing in vitro developed “organoids” and tissue mimicking chips. Microfluidic devices that allow long-term maintenance and combination with other tissues, cells or organoids are commonly referred to as “microphysiological” or “organ-on-a-chip” systems. Organ-on-a-chip technology allows a broad range of “on-chip” and “off-chip” analytical techniques, whereby “on-chip” techniques offer the possibility of real time tracking and analysis. In the rapidly expanding tool kit for real time analytical assays, mass spectrometry, combined with “on-chip” electrophoresis, and other separation approaches offer attractive emerging tools. In this review, we provide an overview of current 3D cell culture models, a compendium of current analytical strategies, and we make a case for new approaches for integrating separation science and mass spectrometry in this rapidly expanding research field.     

Discovery by serendipity: a new context for an old riddle

In the last years there has been a great improvement in the development of computational methods for combinatorial chemistry applied to drug discovery. This approach to drug discovery is sometimes called a “rational way” to manage a well known phenomenon in chemistry: serendipity discoveries. Traditionally, serendipity discoveries are understood as accidental findings made when the discoverer is in quest for something else. This ‘traditional’ pattern of serendipity appears to be a good characterization of discoveries where “luck” plays a key role. In this sense, some initial failures in combinatorial chemistry are frequently attributed to a naïf appropriation of a “serendipity model” for discovery (a “serendipity mistake”). In this paper we try to evaluate this statement by criticizing its foundations. It will be suggested that the notion of serendipity has different aspects and that the criticism to the first attempts could be understood as a “serendipity mistake.” We will suggest that “serendipity” strategies, a kind of blind search, can be seen sometimes as a “genuine part” of scientific practice. A discussion will ensue about how this characterization can give us a better understanding of some aspects of serendipity discoveries.     

Polymeric carriers of drugs for site-specific therapy

Three types of water-soluble polymeric drug carrier systems facilitating targeted drug delivery and controlled drug release were synthesized. All systems consist of an inert soluble synthetic polymer, drug and homing device (targeting moiety). In the first “classical” system, both drug and targeting moiety are bound to a nondegradable polymer by means of biodegradable oligopeptide side chains statistically distributed along the polymer chain. The second, “star-like” system contains a targeting moiety (antibody) in the centre and a hydrophilic polymer, bearing drug molecules, in the shell of the system. The third, “biodegradable” carrier system is based on block copolymers of poly(ethylene glycol) containing biodegradable oligopeptide sequences both in the main polymer chain and in the spacers between main chain and drug molecules. Strategy and details of the synthesis of all three systems are given.     

Strategies and intermediates for fredericamycin a synthesis: A 3-substituted 9-alkoxy cyclopenta(g)isoquinoline-1,8(2H)-dione

A polyketide condensation affords a key intermediate for fredericamycin synthesis. Subsequent reactions yield a model for the “lower ring system” of this antitumor antibiotic.     

4‐Quinolone Derivatives and Their Activities Against Gram‐negative Pathogens

Gram‐negative pathogens represent a significant global health threat, while the emergency and widespread of drug resistance make the situation even worse. As “privileged building blocks,” 4‐quinolones including fluoroquinolones are mainstays of chemotherapy against various bacterial infections. However, as other antibiotics, the resistance of Gram‐negative bacteria to 4‐quinolones develops rapidly and spreads widely throughout the world. To overcome the resistance and improve the potency, a number of 4‐quinolone derivatives were designed, synthesized, and screened for their in vitro and in vivo activities against representative Gram‐negative pathogens. This review aims to summarize the recent advances made towards the discovery of 4‐quinolone derivatives as anti‐Gram‐negative agents as well as their structure–activity relationship. The enriched structure–activity relationship paves the way to the further rational development of 4‐quinolones with excellent potency against both drug‐susceptible and drug‐resistant Gram‐negative pathogens.     

Novel Supports Based on Polysaccharides for Sustained‐Release of Isosorbide Dinitrate

Novel supports based on carboxymethylcellulose (CMC), crosslinked with epichlorohydrin (EPC), and microparticles based on acetylphthalylcellulose (APC), for sustained‐release of isosorbide dinitrate (Isoket, Ik), were obtained. The drug has been included into CMC hydrogels through diffusion from ethanol‐water solution. Studies about the ethanol–water ratio influence on including the drug have shown an increased amount of included drug at higher content of water in the alcohol‐water mixture. Isoket–ACP microparticles have been obtained by drug and polymer co‐precipitation from emulsified aqueous solution.

The kinetics for “in vitro” release of Ik from polymeric materials, in simulated conditions for intestinal tract medium, where the drug is preferentially absorbed, has been analyzed. The experimental data have shown a “zero” order kinetic for drug release, which is characteristic for systems controlled by diffusion.     

Groups of Organic Molecules That Operate Collectively

A “chemical system” is defined as an assemblage of molecules that collectively does something interesting or useful. The key word here is “collectively”, a word that implies an interdependency and a group behavior that can be quite different from that of individual molecules. Batteries, computer chips, concrete, mayonnaise, shampoo, paint, liquid crystal displays, composites, and viruses are all examples of commonly encountered systems. A host–guest or “supramolecular” complex, on the other hand, would not be considered a system (as defined here), because only two species are involved. A chemical system is multimolecular, a collection of molecules interlocked in a tangle of dependencies. The review delves into a variety of chemical systems investigated by the author, including micelles, water pools, films, vesicles, and polymers. All of them can be categorized as “self-assembling” or “self-organizing” in the sense that defined structures arise spontaneously owing to noncovalent forces among the component molecules. Such chemical systems are useful for many purposes, including decontamination of environmentally dangerous substances, drug delivery, and separation of organic compounds.     

CADD medicine: design is the potion that can cure my disease

The acronym “CADD” is often used interchangeably to refer to “Computer Aided Drug Discovery” and “Computer Aided Drug Design”. While the former definition implies the use of a computer to impact one or more aspects of discovering a drug, in this paper we contend that computational chemists are most effective when they enable teams to apply true design principles as they strive to create medicines to treat human disease. We argue that teams must bring to bear multiple sub-disciplines of computational chemistry in an integrated manner in order to utilize these principles to address the multi-objective nature of the drug discovery problem. Impact, resourcing principles, and future directions for the field are also discussed, including areas of future opportunity as well as a cautionary note about hype and hubris.     

Development of analytical SFE of a polar drug from an animal food matrix

The applicability of supercritical CO₂ extraction as a quantitative method for recovery of a hypolipidemic drug from an animal food matrix has been evaluated. Off-line extraction with solid phase trapping and solvent rinsing has been utilized. An optimized method for quantitative extraction of the pure drug was initially developed with high reproducibility. Three drug/rat feed matrices were examined. The as-received “crystalline matrix” yielded the poorest reproducibility suggestive of a heterogeneous matrix. A laboratory-prepared crystalline drug/feed matrix and a matrix prepared by spiking the animal feed with a solution of the drug gave ten-fold better RSDs than the “crystalline matrix”.     

Construction of a pH-responsive drug delivery platform based on the hybrid of mesoporous silica and chitosan

Mesoporous silica nanoparticles (MSN) have been widely used for drug delivery due to their large specific surface area and excellent biocompatibility. However, the mesoporous structure of MSN would lead to the inevitable “premature release” of the drugs, and therefore the modification of MSN for controlled delivery seems to be a necessary step. Herein, chitosan (CS) was used for the surface functionalization of MSN via amidation reaction, and the introduced CS could function as a “gatekeeper” and the drug of methotrexate (MTX) might be encapsulated in the mesopores of MSN. As a result, the “premature release” of the encapsulated MTX could be effectively circumvented with the aid of the CS cap. More importantly, the drug delivery from the hybrid of MSN and CS (MSN/CS) can be endowed with pH-sensitivity by the introduction of CS because the amide bonding between CS and MSN is highly pH-sensitive. The cumulative release of MTX from the MSN/CS is more pronounced at pH 5.0 (80.86%) than those at pH 6.8 (40.46%) and pH 7.4 (18.25%).     

Laser-induced Graphene in Facts,Numbers, and Notes in View of Electroanalytical Applications: A Review

In this review, laser-induced graphene (LIG) -based electrodes are discussed by covering such essential areas, as a characterization of LIG material properties necessary for electroanalysis, including data on LIG sheet resistance, wettability, spatial resolution, electrochemical characteristics, as well as correlations of “process” - “properties” - “electroanalytical characteristics”of LIG-electrodes. Moreover, typical and innovative LIG-based electrodes designs for electroanalytical applications, including combined multi-analyte multimodal wearable sensors, interdigitated electrodes, are shown. The essential data related to LIG in electroanalysis are summarized in tables. The authors also discussed recent LIG-based electroanalytical applications. Close attention has been paid to LIG glucose sensors and biosensors.     

Electrochemical behavior of tungsten-containing nanocomposite with siloxane matrix

Electrochemical properties of a thin-film nanocomposite “silicon-carbon matrix-tungsten carbide” deposited onto pyroceramics (“sitall”) substrate are studied by potentiodynamic curves and electrochemical impedance spectroscopy. Transfer coefficients in model redox system [Fe(CN)₆]^3?/4? are measured. With the decreasing of the films’ electrical resistance, their experiment behavior gradually changed from that of “poor conductor” till nearly metal-like one. In particular, the electrode differential capacitance increases, which is explained by the increase in the number of conducting metal-containing clusters in the film bulk and at the film/electrolyte solution interface. Some specific features of the complex-plane plots of impedance spectra are tentatively explained by the adsorption at the nanocomposite surface elements.